Combination treatment with a tumour necrosis factor antagonist and an oral retinoid: efficacy in severe acral psoriasis?

Br J Dermatol. 2012 Oct;167(4):949-51. doi: 10.1111/j.1365-2133.2012.10983.x. Epub 2012 Jul 5.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acitretin / therapeutic use*
  • Adolescent
  • Alitretinoin
  • Antibodies, Monoclonal / therapeutic use*
  • Dermatologic Agents / therapeutic use*
  • Drug Therapy, Combination
  • Humans
  • Infliximab
  • Male
  • Psoriasis / drug therapy*
  • Severity of Illness Index
  • Treatment Outcome
  • Tretinoin / therapeutic use*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Dermatologic Agents
  • Tumor Necrosis Factor-alpha
  • Alitretinoin
  • Tretinoin
  • Infliximab
  • Acitretin